SV Health Investors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

SV Health Investors’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-449,951	Closed	-$15.3M	–	8
2021 Q3	$15.3M	Hold	449,951	–	–	7.48%	5
2021 Q2	$16.5M	Hold	449,951	–	–	7.18%	5
2021 Q1	$20.2M	Hold	449,951	–	–	7.56%	5
2020 Q4	$25.7M	Hold	449,951	–	–	12.37%	5
2020 Q3	$23.1M	Hold	449,951	–	–	11.69%	3
2020 Q2	$26.9M	Hold	449,951	–	–	18.64%	2
2020 Q1	$18.5M	Hold	449,951	–	–	15.54%	4
2019 Q4	$28M	Sell	449,951 -92,192	-17%	-$4.38M	16.96%	4
2019 Q3	$18.4M	Sell	542,143 -376,194	-41%	-$11.1M	12.93%	5
2019 Q2	$20.7M	Sell	918,337 -319,861	-26%	-$7.49M	13.9%	4
2019 Q1	$28.7M	Sell	1,238,198 -49,029	-4%	-$1.28M	16.86%	3
2018 Q4	$27M	Sell	1,287,227 -429,076	-25%	-$10.5M	16.63%	3
2018 Q3	$66.5M	Hold	1,716,303	–	–	19.46%	2
2018 Q2	$67.5M	Hold	1,716,303	–	–	31.01%	2
2018 Q1	$34.4M	Hold	1,716,303	–	–	25.79%	2
2017 Q4	$38.9M	Hold	1,716,303	–	–	20.55%	2
2017 Q3	$32.6M	Buy	+1,716,303	New	+$31.4M	24.72%	2

Other funds holding DCPH

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

SV Health Investors's DCPH Position: Q4 2021 in Review

SV Health Investors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2021, closing a stake of 449,951 shares — an estimated $15.3M sold.

SV Health Investors first reported a position in DCPH in Q3 2017 and held it in 17 quarters. The position peaked at $67.5M in Q2 2018. 140 funds tracked by Wall St. Rank hold DCPH as of Q4 2021.

SV Health Investors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
SV Health Investors sold 449,951 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $15.3M.
SV Health Investors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 17 quarters.
SV Health Investors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $67.5M in Q2 2018.
140 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on SV Health Investors's 13F filing for Q4 2021, filed 11 Feb 2022.